Gain Therapeutics announces $100M mixed shelf offering

1 day ago 1

Gain Therapeutics (NASDAQ:GANX) has filed a shelf registration to offer up to $100M in various securities.
The potential offerings may include common stock, preferred stock, warrants, debt securities, subscription rights, or units.
GANX shares rise nearly 3% post-market on Wednesday.
Source: SEC filing

Recommended For You